EMEA-001748-PIP01-15-M01

Key facts

Active substance
Arimoclomol (citrate)
Therapeutic area
Neurology
Decision number
P/0213/2018
PIP number
EMEA-001748-PIP01-15-M01
Pharmaceutical form(s)
Capsule hard
Condition(s) / indication(s)
Treatment of Niemann-Pick disease, type C
Route(s) of administration
Oral use
Contact for public enquiries
Orphazyme A/S

E-mail: amh@orphazyme.com
Tel. +45 2898 9056

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating